Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Exploris 480
ORGANISM(S): Mus Musculus (mouse)
TISSUE(S): Cell Culture, Macrophage
DISEASE(S): Lung Carcinoma
SUBMITTER: Marcel Schilling
LAB HEAD: Prof. Ursula Klingmüller
PROVIDER: PXD040145 | Pride | 2024-04-18
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
MaxQuant_Output.7z | Other | |||
OTEX_211129_21-022_04_old_1.raw | Raw | |||
OTEX_211129_21-022_06_old_2.raw | Raw | |||
OTEX_211129_21-022_08_old_3.raw | Raw | |||
OTEX_211129_21-022_10_old_4.raw | Raw |
Items per page: 1 - 5 of 68 |
ACS nano 20240416 17
ALK-positive NSCLC patients demonstrate initial responses to ALK tyrosine kinase inhibitor (TKI) treatments, but eventually develop resistance, causing rapid tumor relapse and poor survival rates. Growing evidence suggests that the combination of drug and immune therapies greatly improves patient survival; however, due to the low immunogenicity of the tumors, ALK-positive patients do not respond to currently available immunotherapies. Tumor-associated macrophages (TAMs) play a crucial role in fa ...[more]